Murphy Katrina, Gerzanich Volodymyr, Zhou Hui, Ivanova Svetlana, Dong Yafeng, Hoffman Gloria, West G Alexander, Winn H Richard, Simard J Marc
Department of Neurosurgery, University of Maryland School of Medicine, 22 South Greene St., Baltimore MD 21201-1595, USA.
Mol Pharmacol. 2003 Sep;64(3):640-9. doi: 10.1124/mol.64.3.640.
Adenosine acting via A2a receptors (A2aR) is a potent cerebral vasodilator that relaxes vascular smooth muscle cells (VSMCs) by a mechanism attributed to activation of cAMP-dependent protein kinase (cAK). We examined effects of adenosine and its mechanism of action on L-type Ca2+ channels in native VSMCs from rat basilar artery. Reverse transcription-polymerase chain reaction and immunofluorescence imaging confirmed transcription and expression of A2aR, and in situ hybridization confirmed presence of mRNA for L-type Cav1.2b channels. In patch-clamp experiments, adenosine down-regulated Ca2+ channel currents in a concentration-dependent manner, with receptor-subtype-specific antagonists [4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolo-[2,3-a][1,3,5]triazin-5-ylamino]ethyl)phenol (ZM-241385) versus 1,3-dipropyl-8-cyclopentyl-1,3-dipropylxanthine] showing that this was caused by action of A2aR. Down-regulation of channel currents was mimicked by stimulation of cGMP-dependent protein kinase (cGK; 8-Br-cGMP) and by inhibition of tyrosine kinase (AG-18) but not by stimulation of cAK [forskolin and 8-bromo-cAMP (8-Br-AMP)]. Down-regulation of currents by the A2aR agonist 2-[p-(2-carboxyeth yl)phenylethylamino]-5'-N-ethyolcarboxamidoadenosine (CGS-21680) was blocked by inhibiting protein tyrosine phosphatase (PTP; orthovanodate and dephostatin), but not by inhibiting cGK (KT-5823 and H-7). Western blots of lysate or of immunoisolated Ca2+ channels from arterial segments incubated with CGS-21680 showed 1) increased phosphorylation of vasodilator-stimulated phosphoprotein that was blocked by inhibiting cAK (KT-5720), consistent with activation of cAK by A2aR; and 2) decreased tyrosine phosphorylation of immunoisolated alpha1c subunit of the Ca2+ channel. Our data show that cAK, although activated, was not germane to down-regulation of Ca2+ channel activity by A2aR, and they delineate a novel signaling mechanism involving reduced tyrosine phosphorylation of Ca2+ channels by A2aR probably caused by PTP activation.
通过A2a受体(A2aR)起作用的腺苷是一种强效的脑血管扩张剂,它通过一种归因于环磷酸腺苷(cAMP)依赖性蛋白激酶(cAK)激活的机制使血管平滑肌细胞(VSMC)松弛。我们研究了腺苷对大鼠基底动脉原代VSMC中L型Ca2+通道的作用及其作用机制。逆转录-聚合酶链反应和免疫荧光成像证实了A2aR的转录和表达,原位杂交证实了L型Cav1.2b通道mRNA的存在。在膜片钳实验中,腺苷以浓度依赖性方式下调Ca2+通道电流,受体亚型特异性拮抗剂[4-(2-[7-氨基-2-(2-呋喃基)[1,2,4]三唑并-[2,3-a][1,3,5]三嗪-5-基氨基]乙基)苯酚(ZM-241385)与1,3-二丙基-8-环戊基-1,3-二丙基黄嘌呤]表明这是由A2aR的作用引起的。cGMP依赖性蛋白激酶(cGK;8-溴-cGMP)的刺激和酪氨酸激酶的抑制(AG-18)模拟了通道电流的下调,但cAK的刺激[福斯可林和8-溴-环磷酸腺苷(8-Br-AMP)]则没有。A2aR激动剂2-[对-(2-羧乙基)苯乙氨基]-5'-N-乙基羧酰胺腺苷(CGS-21680)引起的电流下调被蛋白酪氨酸磷酸酶(PTP;原钒酸盐和去磷抑素)的抑制所阻断,但未被cGK的抑制(KT-5823和H-7)所阻断。用CGS-21680孵育的动脉段裂解物或免疫分离的Ca2+通道的蛋白质免疫印迹显示:1)血管舒张刺激磷蛋白的磷酸化增加,这被cAK的抑制(KT-5720)所阻断,这与A2aR激活cAK一致;2)免疫分离的Ca2+通道α1c亚基的酪氨酸磷酸化减少。我们的数据表明,虽然cAK被激活,但它与A2aR对Ca2+通道活性的下调无关,并且它们描绘了一种新的信号传导机制,即A2aR可能通过PTP激活导致Ca+通道酪氨酸磷酸化减少。